Literature DB >> 14684992

Dppa3 is a marker of pluripotency and has a human homologue that is expressed in germ cell tumours.

J Bowles1, R P Teasdale, K James, P Koopman.   

Abstract

We identified a transcript named 11M2 on the basis of its strong male-specific expression pattern in the developing mouse gonad. 11M2 was found to be expressed by gonad primordial germ cells (PGCs) of both sexes and down-regulated in female PGCs as they enter prophase I of the first meiotic division, similar to the expression of OCT4. Mouse EST analysis revealed expression only in early-stage embryos, embryonic stem cells and pre-meiotic germ cells. 11M2 corresponds to a recently reported gene variously known as PGC7, STELLA or DPPA3. We have identified the human orthologue of DPPA3 and find by human EST analysis that it is expressed in human testicular germ cell tumours but not in normal human somatic tissues. The expression patterns of mouse and human DPPA3, in undifferentiated embryonic cells, embryonic germ cells and adult germ cell tumours, together suggest a role for this gene in maintaining cell pluripotentiality. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684992     DOI: 10.1159/000074346

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  23 in total

1.  Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation.

Authors:  Peili Gu; Damien LeMenuet; Arthur C-K Chung; Michael Mancini; David A Wheeler; Austin J Cooney
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 2.  Microinvasive germ cell tumor of the testis.

Authors:  Finn Edler von Eyben; Grete Krag Jacobsen; Rolf Inge Skotheim
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

3.  RNA expression microarray analysis in mouse prospermatogonia: identification of candidate epigenetic modifiers.

Authors:  Christophe Lefèvre; Jeffrey R Mann
Journal:  Dev Dyn       Date:  2008-04       Impact factor: 3.780

4.  STELLA-positive subregions of the primitive streak contribute to posterior tissues of the mouse gastrula.

Authors:  Maria M Mikedis; Karen M Downs
Journal:  Dev Biol       Date:  2011-10-08       Impact factor: 3.582

5.  Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.

Authors:  Caryl J Giuliano; Sarah J Freemantle; Michael J Spinella
Journal:  Curr Cancer Ther Rev       Date:  2006-08-01

6.  PRDM1/BLIMP1 is widely distributed to the nascent fetal-placental interface in the mouse gastrula.

Authors:  Maria M Mikedis; Karen M Downs
Journal:  Dev Dyn       Date:  2016-11-12       Impact factor: 3.780

7.  Interaction between DMRT1 function and genetic background modulates signaling and pluripotency to control tumor susceptibility in the fetal germ line.

Authors:  Anthony D Krentz; Mark W Murphy; Teng Zhang; Aaron L Sarver; Sanjay Jain; Michael D Griswold; Vivian J Bardwell; David Zarkower
Journal:  Dev Biol       Date:  2013-03-06       Impact factor: 3.582

8.  Widespread but tissue-specific patterns of interferon-induced transmembrane protein 3 (IFITM3, FRAGILIS, MIL-1) in the mouse gastrula.

Authors:  Maria M Mikedis; Karen M Downs
Journal:  Gene Expr Patterns       Date:  2013-04-29       Impact factor: 1.224

9.  In vitro germ cell differentiation from cynomolgus monkey embryonic stem cells.

Authors:  Kaori Yamauchi; Kouichi Hasegawa; Shinichiro Chuma; Norio Nakatsuji; Hirofumi Suemori
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

10.  Ontological differences in first compared to third trimester human fetal placental chorionic stem cells.

Authors:  Gemma N Jones; Dafni Moschidou; Tamara-Isabel Puga-Iglesias; Katarzyna Kuleszewicz; Maximilien Vanleene; Sandra J Shefelbine; George Bou-Gharios; Nicholas M Fisk; Anna L David; Paolo De Coppi; Pascale V Guillot
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.